Question explored with the scientific record
Conversation so far
- …started from a private conversation
- 1 What tests confirm Sjögren’s and kidney involvement specifically?
- 2 plus a nodule to the thiroid
Answered on this page ↓
plus a nodule to the thiroid
The short version: a thyroid nodule in a Sjögren’s patient needs the same workup as in anyone else, but Sjögren’s raises the chance of thyroid autoimmunity and lymphocytic infiltration, which can complicate ultrasound and biopsy interpretation.
The evidence here covers two separate questions: how to evaluate a thyroid nodule, and how Sjögren’s kidney disease presents. The thyroid nodule studies are large and well-validated. The Korean multicenter study of 1,796 patients built a scoring system from ultrasound features—hypoechogenicity, non-parallel orientation, spiculated margins, microcalcifications—that predicts malignancy with an AUC of about 0.87 in validation [11]. A 2025 study of 278 cystic-solid nodules added radiomics and deep learning to reach an AUC of 0.913 [12]. The mTI-RADS system, designed specifically for nodules in Hashimoto’s thyroiditis (an autoimmune thyroid condition that overlaps with Sjögren’s), found malignancy rates from 3.7% in low-risk to 94.1% in high-risk categories [16]. These systems work.
The problem is that Sjögren’s itself can cause lymphocytic infiltration of the thyroid that looks suspicious on ultrasound. The mTI-RADS study was done in Hashimoto’s patients, not Sjögren’s, and the authors note that autoimmune thyroiditis changes the background tissue, making it harder to distinguish benign from malignant nodules [16]. No study here directly tests how Sjögren’s affects thyroid nodule ultrasound interpretation. That is a gap.
For the kidney part, the evidence is consistent. Sjögren’s kidney involvement is most often distal renal tubular acidosis (dRTA), which shows up as a normal-anion-gap metabolic acidosis with a urine pH above 5.5, low potassium, and often nephrocalcinosis on imaging [1, 2, 7]. The prevalence of dRTA in Sjögren’s ranges from 6.8% to 70% across studies [4]. A kidney biopsy is the gold standard for the less common glomerulonephritis patterns, which carry worse prognosis [9].
The thyroid nodule and the kidney disease are separate problems that happen to coexist in the same patient. The kidney disease does not change how you evaluate the nodule, and the nodule does not change how you treat the kidney disease.
| Test or system | What it tells you | Evidence quality |
|---|---|---|
| TIRADS or mTI-RADS ultrasound | Malignancy risk from nodule features | High, validated in thousands [11, 16] |
| FNA biopsy with Bethesda cytology | Cell-level diagnosis | High, but indeterminate results are common [13, 30] |
| BRAF V600E testing on FNA | Adds specificity for papillary cancer | Moderate, best in high-prevalence areas [35] |
| Serum creatinine, urinalysis | Screens for kidney involvement | Moderate, abnormal results need follow-up [1, 2, 7] |
| Kidney biopsy | Gold standard for kidney pathology | High, but invasive [9] |
My call: get a TIRADS-classified ultrasound for the nodule, and if the nodule is suspicious (category 4b or higher), get an FNA. For the kidney, start with a basic metabolic panel and urinalysis; if the bicarbonate is low or the urine pH is above 5.5, check for dRTA with a urine anion gap and consider a kidney biopsy if glomerulonephritis is suspected. The evidence for the thyroid workup is strong. The evidence for how Sjögren’s specifically changes thyroid nodule interpretation is absent from this retrieval. Confidence: moderate for the thyroid workup, moderate for the kidney workup, low for the interaction between the two.
Sources used 11
-
Distal Renal Tubular Acidosis Associated with Sjögren's Syndrome
This study presents a case of a 61-year-old woman with Sjögren's syndrome who developed distal renal tubular acidosis, highlighting the association between these conditions and the importance of monitoring renal function in such patients.
DOI: 10.2169/internalmedicine.51.6975 -
The Case ∣ Hypokalemia associated with nephrocalcinosis
This case study presents a 43-year-old female with hypokalemia associated with nephrocalcinosis, revealing a potential link to Sjögren's syndrome and highlighting the role of H+-ATPase in distal renal tubular acidosis.
DOI: 10.1038/ki.2008.530 -
Exploring the Interaction Between Sjögren’s Syndrome and Osteoporosis: Pathophysiological Mechanisms and Management Strategies
This narrative review synthesizes the bidirectional relationship between Sjögren's syndrome (SS) and osteoporosis (OP), detailing shared pathophysiological mechanisms (including vitamin D metabolism, sex hormones, and RANKL/RANK/OPG signaling), the impact of SS treatments on bon…
DOI: 10.2147/IJGM.S543209 -
Renal Tubular Acidosis in Patients with Primary Sjögren's Syndrome
Two case reports describe distal renal tubular acidosis due to primary Sjögren's syndrome presenting with hypokalemic metabolic acidosis and osteomalacia, highlighting diagnostic challenges and favorable responses to immunosuppressive therapy.
DOI: 10.5049/EBP.2017.15.1.17 -
Kidney biopsy findings in primary Sjögren syndrome
This study investigates renal biopsy findings in 25 patients with primary Sjogren syndrome, revealing diverse pathological outcomes and highlighting the association of glomerulonephritis with higher early mortality compared to tubulointerstitial nephritis.
DOI: 10.1093/ndt/gfv042 -
Image Reporting and Characterization System for Ultrasound Features of Thyroid Nodules: Multicentric Korean Retrospective Study
A multicenter Korean retrospective study developed and validated a simple ultrasound feature–based scoring model to predict malignancy risk in thyroid nodules, achieving an area under the ROC curve around 0.87 and supporting risk-stratified biopsy decisions.
DOI: 10.3348/kjr.2013.14.1.110 -
Malignant risk prediction of cystic-solid thyroid nodules using a comprehensive model integrating clinical and ultrasound features, ultrasound radiomics, and deep transfer learning
A retrospective study (n=278 CSTN) develops and validates a comprehensive nomogram that integrates clinical + ultrasound features, ultrasound radiomics, and deep transfer learning to predict malignancy risk in cystic-solid thyroid nodules, outperforming models based on radiomics…
DOI: 10.21037/gs-2024-551 -
Factors Predicting Thyroid Malignancy in Fine Needle Aspiration Biopsy Specimens Classified as Atypia of Uncertain Significance/Follicular Lesion of Uncertain Significance
A four-year retrospective analysis of AUS/FLUS thyroid fine-needle aspiration biopsies evaluated whether ultrasound features and histopathologic subtyping predict malignancy; neither ultrasound characteristics nor subcategorization significantly improved malignancy risk stratifi…
DOI: 10.1177/000313481808400740 -
A Modified Thyroid Imaging Reporting and Data System (mTI-RADS) For Thyroid Nodules in Coexisting Hashimoto’s Thyroiditis
This study develops a modified Thyroid Imaging Reporting and Data System (mTI-RADS) to stratify the malignancy risk of thyroid nodules in patients with coexisting Hashimoto's thyroiditis, demonstrating significant predictive features for malignancy and establishing a scoring sys…
DOI: 10.1038/srep26410 -
Bethesda classification is a valuable guide for fine needle aspiration reports and highly predictive especially for diagnosing aggressive variants of papillary thyroid carcinoma
This study evaluates the malignancy rates of thyroid nodules classified by the Bethesda System for Reporting Thyroid Cytopathology, highlighting its predictive value for aggressive variants of papillary thyroid carcinoma.
DOI: 10.1111/cyt.12384 -
Detection of BRAF V600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto‐pathology diagnosis, especially in BRAF V600E mutation‐prevalent area
In Korea, where classic papillary thyroid carcinoma and BRAF V600E mutation are highly prevalent, detection of BRAF V600E mutation in FNAB specimens refines cytopathology diagnosis, and direct DNA sequencing outperforms PCR-RFLP in diagnostic accuracy.
DOI: 10.1111/j.1365-2265.2006.02646.x